Pediatric Vaccines in Healthy Infants and Toddlers (Meningococcal Conjugate Vaccine)

Meningococcal conjugate vaccine is used to prevent infection caused by meningococcal bacteria. Learn More

Phase: III

Time frame: 14 months

Age requirements: ≥ 42  to  ≤ 89 days on the day of the first study visit

Compensation: Group 1a up to $720

Group 1b and 2b up to $840

Group 2a up to $960


Key Inclusion Criteria:

  •  Healthy infants ≥42 to ≤ 89 days on the day of the first study visit.
  • Subject and parent/ guardian are able to attend all scheduled visits and to comply with all trial procedures.
  • Infants who received the first dose of hepatitis B vaccine at least 28 days before the first study visit.


Additional Criteria:
At screening visit, additional criteria will be reviewed to determine eligibility for the study. Qualified participants will receive study medication, medical care and compensation for the time and travel of each completed study visit.

Back to list


Thank you for your interest in our studies. Please use the following form to begin your enrollment process in a clinical trial or to join our database of opted-in patients. You will receive notification via email and/or regular mail about new clinical trial opportunities.

Fields marked with an asterisk (*) are required.

I am interested in the following studies:

By completing this form, you are not committing to participate in a clinical research study or being selected as a study participant. You will be given the option to select whether or not you'd like to be considered for potential participation.